European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
Alexandra SerrisRiina Rautemaa-RichardsonJoana LaranjinhaAnna CandoniCarolina García-VidalAna-Alastruey IzquierdoHelena HammarströmDanila SeidelJan StyczyńskiRaquel SabinoFrederic LamothJuergen PrattesAdilia WarrisRapahël PorcherFanny Lanterniernull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Isavuconazole appears to be a well-tolerated treatment. Mortality of CA treated with isavuconazole is similar to that reported with voriconazole.